Literature DB >> 7538018

Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins alpha IIb beta 3, alpha V beta 3 and alpha 5 beta 1 and in cell adhesion inhibition.

M Pfaff1, M A McLane, L Beviglia, S Niewiarowski, R Timpl.   

Abstract

The inhibitory capacities of six different disintegrins and one related neurotoxin analogue for the binding of RGD-dependent integrins to either fibrinogen, vitronectin or fibronectin were compared in solid phase assays. Echistatin and flavoridin were the most active inhibitors for alpha V beta 3 and alpha 5 beta 1 integrins and moderately exceeded the activity of the natural protein ligands. The same disintegrins together with eristostatin, bitistatin and barbourin were also very potent inhibitors of fibrinogen binding to alpha IIb beta 3 integrin. For all three integrins, albolabrin showed the lowest affinity, but it still clearly exceeded that of synthetic GRGDS. However, assay conditions may determine these relative affinities, as shown for the alpha IIb beta 3 and alpha V beta 3 integrins when used either in immobilized or soluble form. For alpha IIb beta 3, however, a close correlation was found between KD values determined in platelet binding assays and the concentrations required for half maximal inhibition of three disintegrins. The inhibiting capacity of disintegrins in assays with purified integrins also correlated reasonably well with their inhibition of cell attachment to RGD-dependent protein substrates. However, sequence differences in the RGD loops of the various disintegrins may not fully account for the 20-100-fold difference in their binding capacities. This was particularly evident for echistatin and albolabrin, which differ in this region only by two conservative substitutions but have considerably different inhibitory activities. More remote regions of the disintegrins and alignment of disulfide bridges are therefore likely to contribute to their affinity and selectivity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7538018     DOI: 10.3109/15419069409014213

Source DB:  PubMed          Journal:  Cell Adhes Commun        ISSN: 1023-7046


  28 in total

1.  Promotion of neurite and filopodium formation by CD47: roles of integrins, Rac, and Cdc42.

Authors:  Motoaki Miyashita; Hiroshi Ohnishi; Hideki Okazawa; Hiroyasu Tomonaga; Akiko Hayashi; Tetsuro-Takahiro Fujimoto; Nobuhiko Furuya; Takashi Matozaki
Journal:  Mol Biol Cell       Date:  2004-06-23       Impact factor: 4.138

2.  A crosstalk between β1 and β3 integrins controls glycine receptor and gephyrin trafficking at synapses.

Authors:  Cécile Charrier; Patricia Machado; Ry Y Tweedie-Cullen; Dorothea Rutishauser; Isabelle M Mansuy; Antoine Triller
Journal:  Nat Neurosci       Date:  2010-10-10       Impact factor: 24.884

3.  Differential recognition of snake venom proteins expressing specific Arg-Gly-Asp (RGD) sequence motifs by wild-type and variant integrin alphaIIbbeta3: further evidence for distinct sites of RGD ligand recognition exhibiting negative allostery.

Authors:  S Rahman; G Flynn; A Aitken; Y Patel; F Hussain; X Lu; J C Loftus; D French; E Wijelath; K Strand; G F Savidge
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

4.  Disulphide-bond pattern and molecular modelling of the dimeric disintegrin EMF-10, a potent and selective integrin alpha5beta1 antagonist from Eristocophis macmahoni venom.

Authors:  J J Calvete; M Jürgens; C Marcinkiewicz; A Romero; M Schrader; S Niewiarowski
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

5.  In the newborn hippocampus, neurotrophin-dependent survival requires spontaneous activity and integrin signaling.

Authors:  Sachiko Murase; David F Owens; Ronald D McKay
Journal:  J Neurosci       Date:  2011-05-25       Impact factor: 6.167

6.  Regulation of endothelial cell activation and angiogenesis by injectable peptide nanofibers.

Authors:  Hongkwan Cho; Swathi Balaji; Abdul Q Sheikh; Jennifer R Hurley; Ye F Tian; Joel H Collier; Timothy M Crombleholme; Daria A Narmoneva
Journal:  Acta Biomater       Date:  2011-09-06       Impact factor: 8.947

7.  Immunological characterization of eristostatin and echistatin binding sites on alpha IIb beta 3 and alpha V beta 3 integrins.

Authors:  C Marcinkiewicz; L A Rosenthal; D M Mosser; T J Kunicki; S Niewiarowski
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

8.  Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects.

Authors:  Richard H Kimura; Zhen Cheng; Sanjiv Sam Gambhir; Jennifer R Cochran
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

9.  Differences in binding of (99m)Tc-disintegrins to integrin alphavbeta3 on tumor and vascular cells.

Authors:  Linda C Knight; Jan E Romano; Stephen C Cosenza; Nabisa M Iqbal; Cezary Marcinkiewicz
Journal:  Nucl Med Biol       Date:  2007-05       Impact factor: 2.408

10.  Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity.

Authors:  Richard H Kimura; Aron M Levin; Frank V Cochran; Jennifer R Cochran
Journal:  Proteins       Date:  2009-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.